ArticleNeuropsychiatric disease and treatment2026
The Association of Thyroid Function on Cognition and Neuropsychiatric Symptoms in Patients with Cognitive Impairment.
Article in Neuropsychiatric disease and treatment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This study aims to investigate the association between thyroid function, cognitive status, and neuropsychiatric symptoms (NPSs) in patients with mild cognitive impairment or dementia. Methods: This cross-sectional analysis enrolled 2,289 patients newly diagnosed with mild cognitive impairment or dementia. Based on thyroid-stimulating hormone and free thyroxine levels, patients were classified into euthyroid, hypothyroid, and hyperthyroid groups, with subclinical and overt forms incorporated into their respective categories due to group size distribution. NPSs were assessed using the Neuropsychiatric Inventory. Multivariate logistic regression evaluated associations between thyroid function and NPSs, while linear regression examined relationships with cognitive status. Results: Significant differences in Clinical Dementia Rating-Sum of Boxes (CDRSOB) and Cognitive Abilities Screening Instrument (CASI) scores were observed across the three thyroid function groups (mean CDRSOB: euthyroid = 4.6, hyperthyroidism = 5.4, hypothyroidism = 5.3, p = 0.013; mean CASI: euthyroid = 51.6, hyperthyroidism = 47.2, hypothyroidism = 49.0, p = 0.028). Patients in the hyperthyroid group demonstrated higher odds of experiencing delusion (odds ratio (OR) = 1.61, 95% confidence interval (CI) = 1.12-2.31, p = 0.009), agitation (OR = 1.47, 95% CI = 1.00-2.13, p = 0.048), and moderate to severe hallucination (OR = 1.76, 95% CI = 1.01-2.92, p = 0.037). After adjusting for age, education, and dementia subtypes, patients in the hyperthyroid group had significantly worse CDRSOB scores than those in the euthyroid group (β = 0.66, 95% CI = 0.03-1.3, p = 0.040). Conclusion: This study provides the first structured evaluation of behavioral and psychological symptoms of dementia across thyroid function states in patients with cognitive impairment. Hyperthyroidism was associated with worse global function and a higher prevalence of delusions, agitation, and moderate-to-severe hallucinations. These findings highlight an association between thyroid dysfunction and BPSD (behavioral and psychological symptoms of dementia) in cognitively impaired populations and underscore the importance of careful clinical evaluation of thyroid status.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.